The amount of health care spending in the United States, rightly or wrongly, is looked at as one of our biggest problems. And as long as that spending grows at a rate faster than the economy, it becomes a bigger problem. Over the last few, probably largely due to the recession, health spending growth has moderated, but also has continued to increase well over the rate of GDP growth. Proponents of the federal health reform law claimed that it would put in place a number of initiatives that would limit spending rises, but others have noted that it is just as likely that aspects of the law will accelerate spending. Trends this year and next will prove crucial and a new brief from Mark Farrah Associates looks at current medical expense trends for large health plans, which insure the majority of Americans, including those covered by Medicare and Medicaid. Three companies, Wellpoint, Kaiser and United HealthGroup, paid over 30% of all medical expenses in 2011. (Mark Farrah Report) The brief finds that medical cost trend for all health plans did grow more rapidly in 2011, by 5.5%. On a per capita basis, the increase was only 2.4%. Hospital spending was relatively increased and drug spending relatively down. About 86% of all insurance premiums went to medical expenses in 2011, roughly the same as in 2010. Mark Farrah suggests, however, that medical spending was beginning to tick up in 2011 and that their early analysis of 2012 suggests further growth. There are other warning signs that providers are beginning to increase prices to health plans and that consumers are beginning to spend more on medical care after pulling back during the recession.
Where is Medical Cost Trend Going?
By Kevin RocheFebruary 18, 2013Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
March 27, 2023
Why You Can’t Trust People Who Make Up Stuff About Vax Safety
A couple of studies offer a far better explanation for heart issues in athletes and…
March 25, 2023
Coronamonomania Lives Forever, Part 201
Tired of March Madness? A boringly refreshing dip into some CV-19 research summaries is recommended.
March 24, 2023
The CDC Is a Font of Methodological and Statistical Error
Several times in the last three years I and others have pointed out serious flaws…